Quarterly and annual results disclosed under 8-K Item 2.02.
Golub Capital BDC 3, Inc. reported financial results for second fiscal quarter ended March 31, 2024.
“On May 9, 2024, Golub Capital BDC 3, Inc. will host a conference call to discuss its financial results for its second fiscal quarter ended March 31, 2024.”
Target Hospitality Corp. reported the three months ended March 31, 2024 results: revenue $106.7 million, net income $20.4 million, EPS $0.20. Guidance reaffirmed.
“accommodations and value-added hospitality services, today reported results for the three months ended March 31, 2024. Financial and Operational Highlights ● Revenue of $106.7 million for the three months ended March 31, 2024. ● Net income of $20.4 million for the three months ended March 31, 2024. ● Basic and diluted income per share of $0.20 fo r the three”
National Vision Holdings, Inc. reported the first quarter ended March 30, 2024 results: revenue $542.5 million, net income $11.7 million, EPS $0.16. Guidance reaffirmed.
“National Vision Holdings, Inc. Reports First Quarter 2024 Financial Results First Quarter 2024 Continuing Operations Highlights (1) : • Net revenue of $542.5 million , an increase of 4.2% from $520.8 million • Comparable store sales growth of 1.4% and Adjusted Comparable Store Sales Growth of 0.4% • Total Company Net income of $11.7 million • Adjusted Operating Income of $35.8 million • Diluted EPS of $0.16 and Adjusted Diluted EPS of $0.30”
Zai Lab Ltd reported the first quarter of 2024 results: revenue $87.1 million, net income $53.5 million, EPS loss per ordinary share attributable to common stockholders of $0.05 (or loss per American Deposit Share (ADS) of $0.55).
“by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates – Net product revenue of $87.1 million for the first quarter of 2024, representing 39% y-o-y growth; 43% y-o-y growth at constant exchange rate (CER) – VYVGART ® (efgartigimod alfa injection) sales of $13.2 million”
Accel Entertainment, Inc. reported first quarter ended March 31, 2024 results: revenue $301.8 million, net income $7.4 million.
“• Ended Q1 2024 with 3,987 locations; an increase of 5.1% compared to Q1 2023 • Ended Q1 2024 with 25,321 gaming terminals; an increase of 5.6% compared to Q1 2023 • Revenues of $301.8 million for Q1 2024; an increase of 2.9% compared to Q1 2023 • Net income of $7.4 million for Q1 2024; a decrease of 19.2% compared to Q1 2023 • Adjusted EBITDA of $46.2 million for Q1”
Vistra Corp. reported the quarter ended March 31, 2024 results: net income $18 million.
“On May 8, 2024, Vistra Corp. (the “Company”) issued a news release announcing, among other matters, its financial results for the quarter ended March 31, 2024.”
Southwest Gas Holdings, Inc. reported for the quarter ended March 31, 2024 results: net income $87.7 million, EPS $1.22 per diluted share. Guidance reaffirmed.
“Southwest Gas Holdings, Inc. Reports First Quarter 2024 Financial Results, Affirms Guidance”
ESTABLISHMENT LABS HOLDINGS INC. reported the three months ended March 31, 2024 results: revenue $37.2 million, net income $16.2 million. Guidance reaffirmed.
“and reconstruction, today announced financial results for the first quarter ended March 31, 2024. First Quarter Highlights and Outlook • First quarter worldwide revenue of $37.2 million. • 2024 revenue guidance remains $174 million to $184 million, an increase of 5% to 11% over 2023. Guidance does not include revenue from Motiva Implants ® in the United States,”
Ramaco Resources, Inc. reported the three months ended March 31, 2024 results: net income $2.0 million, EPS $0.00. Guidance reaffirmed.
“Ramaco Resources, Inc. (NASDAQ: METC, METCB, “Ramaco” or the “Company”), a leading operator and developer of high-quality, low-cost metallurgical coal, today reported financial results for the three months ended March 31, 2024.”
International Money Express, Inc. reported first quarter of 2024 results: revenue $150.4 million, net income $12.1 million, EPS $0.35 per share. Guidance reaffirmed.
“strong operating results for the first quarter of 2024. Financial performance highlights for the first quarter of 2024 compared with the same period last year are: • Revenues of $150.4 million, an increase of 3.5%; • Net income of $12.1 million, an increase of 2.9%; • Diluted EPS of $0.35 per share, an increase of 12.9%; • Adjusted Diluted EPS of $0.43 per share, an”
HF Foods Group Inc. reported first quarter ended March 31, 2024 results: revenue $295.7 million, net income $0.6 million.
“specific reference in such filing. --- EX-99.1 (EX-99.1) --- HF Foods Reports First Quarter 2024 Financial Results Highest Net Revenue Ever Recorded During First Quarter of $295.7 Million Pre-Recorded Earnings Call Webcast Available on Investor Relations Website Las Vegas, NV – May 8, 2024 – HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods”, or the “Company”), a”
ACM Research, Inc. reported first quarter ended March 31, 2024 results: revenue $ 152,191, net income $ 17,433, EPS $ 0.26.
“Three Months Ended March 31, GAAP Non-GAAP(1) 2024 2023 2024 2023 (dollars in thousands, except EPS) Revenue $ 152,191 $ 74,256 $ 152,191 $ 74,256”
International Seaways, Inc. reported first quarter 2024 results: revenue $274.4 million, net income $144.5 million, EPS $2.92 per diluted share.
“the first quarter of 2023, partially offset by lower interest expense from the reduction of debt by nearly $300 million during 2023. Shipping revenues for the first quarter were $274.4 million, compared to $287.1 million for the first quarter of 2023. Consolidated TCE revenues (1) for the first quarter were $270.9 million, compared to $283.3 million for the first”
VALVOLINE INC reported fiscal second quarter ended March 31, 2024 results: revenue $389 million, net income $43 million, EPS $0.33.
“Valvoline Inc. Reports Second Quarter Results Delivers 7.7% system-wide SSS growth and 38 net store additions • Sales from continuing operations of $389 million grew 13%, driven by system-wide same store sales (SSS) growth of 7.7% • Reported income from continuing operations of $43 million grew 32% and earnings per diluted share (EPS) of $0.33 increased 74%”
CRISPR Therapeutics AG reported financial results for first quarter ended March 31, 2024.
“On May 8, 2024, CRISPR Therapeutics AG announced its financial results for the quarter ended March 31, 2024”
Trade Desk, Inc. reported first quarter ended March 31, 2024 results: revenue $491 million, net income $32 million, EPS $0.06 per diluted share.
“for buyers of advertising, today announced financial results for its first quarter ended March 31, 2024. “Q1 was a strong quarter for The Trade Desk as we delivered revenue of $491 million, accelerating growth to 28% year-over-year. Our outstanding performance to start the year underlines the value advertisers are placing on premium inventory on the open internet”
Immunocore Holdings plc reported the first quarter ended March 31, 2024 results: revenue Total net product revenue ... was $70.3 million in the first quarter of 2024, net income Net loss for the first quarter of 2024 was $24.4 million, EPS The first quarter basic and diluted loss per share was $0.49.
“On May 8, 2024, Immunocore Holdings plc (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024, as well as other recent corporate updates.”
Aptevo Therapeutics Inc. reported the quarter ended March 31, 2024 results: net income a net loss of $6.8 million or $9.95 per share, EPS $9.95 per share.
“Aptevo Therapeutics Inc. (Nasdaq: APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIRTM and ADAPTIR-FLEXTM platform technologies, today reported financial results for the quarter ended March 31, 2024 and provided a business update.”
NeueHealth, Inc. reported first quarter ended March 31, 2024 results: revenue $245,095, net income $5,688. Guidance reaffirmed.
“Metrics Value-Based Consumers served 360,000 373,000 Enablement Services Lives 109,000 27,000 Three Months Ended ($ in thousands) March 31, 2024 2023 Financial Metrics Revenue $ 245,095 $ 300,550 Net Income (Loss) from Continuing Operations $ 5,688 $ (53,918) Adjusted EBITDA (non-GAAP) $ 2,529 $ (5,743) See the table at the end of this release for additional”
PetIQ, Inc. reported the first quarter ended March 31, 2024 results: revenue $308.4 million, net income $14.9 million, EPS $0.48. Guidance raised.
“PetIQ, Inc. Reports First Quarter 2024 Financial Results Reports Record First Quarter 2024 Net Sales of $308.4 Million Achieves Record First Quarter Net Income Record Adjusted EBITDA Exceeds Company's First Quarter 2024 Guidance Raises Full Year 2024 Outlook”
Cardlytics, Inc. reported first quarter ended March 31, 2024 results: revenue $67.6 million, net income $(24.3) million, EPS $(0.56) per diluted share. Guidance initiated.
“we delivered another quarter of positive Adjusted EBITDA, in addition to making material improvement to our balance sheet.” First Quarter 2024 Financial Results • Revenue was $67.6 million, an increase of 5% year-over-year, or 8% excluding Entertainment. • Billings, a non-GAAP metric, was $105.2 million, an increase of 10% year-over-year, or 12% excluding”
Keros Therapeutics, Inc. reported quarter ended March 31, 2024 results: net income net loss of $43.1 million.
“Keros reported a net loss of $43.1 million in the first quarter of 2024 as compared to a net loss of $35.8 million in the first quarter of 2023.”
Sezzle Inc. reported first quarter financial results for the period ending March 31, 2024 results: net income GAAP Net Income reached a new quarterly high of $8.0 million in 1Q24, EPS $1.34 for 1Q24. Guidance raised.
“On May 8, 2024, Sezzle Inc. (the “Company”) issued a press release announcing its first quarter financial results for the period ending March 31, 2024.”
C4 Therapeutics, Inc. reported first quarter ended March 31, 2024 results: revenue $3.0 million.
“Total revenue for the first quarter of 2024 was $3.0 million”
Blue Owl Capital Corp reported first quarter ended March 31, 2024 results: EPS $0.47.
“Blue Owl Capital Corporation Reports First Quarter Net Investment Income Per Share of $0.47”
BEYOND MEAT, INC. reported first quarter ended March 30, 2024 results: revenue $75.6 million, net income $54.4 million, EPS $0.84 per common share.
“Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, today reported financial results for its first quarter ended March 30, 2024. First Quarter 2024 Financial Highlights 1 • Net revenues were $75.6 million, a decrease of 18.0% year-over-year. • Gross profit was $3.7 million, or gross margin of 4.9%, compared to gross profit of $6.2 million, or gross margin of 6.7%, in the year-ago period. • Loss from operations was $53.5 million, or operating margin of -70.7%, compared to loss from operations of $57.7 million, or operating margin of -62.6%, in the year-ago period. ◦ Adjusted loss from operations was $46.0 million, or adjusted operating margin of -60.8%, reflecting the exclusion of a $7.5 million accrual related to a consumer class action settlement. • Net loss was $54.4 million, or $0.84 per common share, compared to net loss of $59.0 million, or $0.92 per common share, in the year-ago period. ◦ Adjusted net loss was $46.9 million, or $0.72 p”
Allbirds, Inc. reported first quarter ended March 31, 2024 results: revenue $39.3 million, net income $27.3 million, EPS $0.18 per basic and diluted share. Guidance reaffirmed.
“products in a better way, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Overview • First quarter net revenue decreased 27.6% to $39.3 million versus a year ago, within the Company’s guidance range. • First quarter gross margin improved 680 basis points to 46.9% versus a year ago. • First quarter net loss of $27.3”
Alector, Inc. reported financial results for First Quarter 2024.
“Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today reported first quarter 2024 financial results and recent portfolio and business updates.”
BeOne Medicines Ltd. reported the three months ended March 31, 2024 results: revenue $752 million.
“as Exhibit 99.1 to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- BeiGene Reports First Quarter 2024 Financial Results and Business Updates • Total revenues of $752 million in the first quarter, including product revenue of $747 million, an 82% increase from the prior-year period • BRUKINSA revenue of $489 million, driven by growth in the U.S. and”
Laird Superfood, Inc. reported the three months ended March 31, 2024 results: revenue $9.9 million, net income Net Loss was $1.0 million, or $0.11 per diluted share, EPS $0.11 per diluted share. Guidance raised.
“the confidence that we have in our near-term financial results as well as the long-term strategies and financial future of Laird." First Quarter 2024 Highlights ● Net Sales of $ 9.9 million compared to $9.2 million in the prior quarter, and $ 8.1 million in the corresponding prior year period. ● Wholesale sales increased by 10% year-over-year and contributed 41% of”
Editas Medicine, Inc. reported first quarter 2024 results: net income net loss of $62.0 million, EPS -$0.76.
“For the three months ended March 31, 2024, net loss attributable to common stockholders was $62.0 million, or $0.76 per share, compared to net loss of $49.0 million, or $0.71 per share, for the same period in 2023.”
Vaxcyte, Inc. reported financial results for the first quarter ended March 31, 2024.
“Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced financial results for the first quarter ended March 31, 2024, and provided a business update.”
MasterCraft Boat Holdings, Inc. reported full year fiscal 2024 results: revenue $360 million and $365 million, EPS $0.95 and $1.05. Guidance lowered.
“Consolidated net sales is now expected to be between $360 million and $365 million, with Adjusted EBITDA between $28 million and $30 million, and Adjusted Earnings per share between $0.95 and $1.05.”
MasterCraft Boat Holdings, Inc. reported fiscal 2024 third quarter ended March 31, 2024 results: revenue $95.7 million, net income $3.8 million, EPS $0.23 per diluted share.
“Overview: ▪ Net sales for the third quarter were $95.7 million, down 42.6% from the prior-year period ▪ Net income from continuing operations was $3.8 million, or $0.23 per diluted share ▪ Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.37, down 72.8% from the prior-year period”
ACV Auctions Inc. reported first quarter ended March 31, 2024 results: revenue $146 million, net income ($20) million. Guidance reaffirmed.
“EX-99.1 (EX-99.1) --- ACV Announces First Quarter 2024 Results Delivered 22% Revenue Growth Revenue and Adjusted EBITDA at the High-End of Guidance • First quarter revenue of $146 million • First quarter GAAP net income (loss) of ($20) million • First quarter non-GAAP net income of $1 million • First quarter Adjusted EBITDA of $4 million • Expects 2024 revenue of”
Crescent Capital BDC, Inc. reported the quarter ended March 31, 2024 results: EPS $0.63 per share.
“Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.63 per share and net income of $0.76 per share for the quarter ended March 31, 2024.”
Revolution Medicines, Inc. reported financial results for the quarter ended March 31, 2024.
“On May 8, 2024, Revolution Medicines, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.”
Boxlight Corp reported the first quarter ended March 31, 2024 results: revenue $37.1 million, net income Net loss was $7.1 million, EPS ($0.76). Guidance initiated.
“Financial and Operational Highlights: • Revenue was $37.1 million for the quarter, a decrease of 9.9% from the prior year quarter • Gross profit margin in Q1'24 decreased by 230 basis points to 34.5% due to change in product mix from the prior year quarter • Net loss was $7.1 million , compared to net loss of $2.9 million in the prior year quarter • Net loss per basic and diluted common share was ($0.76), compared to ($0.35) net loss per basic and diluted common share in the prior year quarter”
James River Group Holdings, Inc. reported first quarter 2024 results: net income Net income from continuing operations available to common shareholders $ 20,883 $ 0.53 $ 5,279 $ 0.14, EPS Net income from continuing operations available to common shareholders $ 20,883 $ 0.53 $ 5,279 $ 0.14.
“James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the first quarter 2024 as compared to the same period in 2023: Three Months Ended March 31, Three Months Ended March 31, ($ in thousands, except for share data) 2024 per diluted share 2023 per diluted share Net income from continuing operations available to common shareholders $ 20,883 $ 0.53 $ 5,279 $ 0.14”
Performance Food Group Co reported third quarter and first nine months fiscal 2024 (quarter ended March 30, 2024) results: revenue $13.9 billion, net income $70.4 million, EPS $0.45.
“Generation Third-Quarter Fiscal 2024 Highlights • Total case volume decreased 0.2% • Organic Independent Foodservice case volume increased 4.3% • Net sales increased 0.6% to $13.9 billion • Gross profit improved 3.8% to $1.6 billion • Net income decreased 12.3% to $70.4 million • Adjusted EBITDA increased 1.9% to $320.7 million 1 • Diluted Earnings Per Share”
Vista Outdoor Inc. reported financial results for the fiscal quarter and fiscal year ended March 31, 2024.
“On May 8, 2024, Vista Outdoor Inc. ("Vista Outdoor" or the "Company") issued a press release reporting its financial results for the fiscal quarter and fiscal year ended March 31, 2024.”
Liberty Broadband Corp reported financial results for first quarter 2024.
“On May 8, 2024, Liberty Broadband Corporation (the "Company") issued a press release (the "Earnings Release") setting forth information, including financial information, which is intended to supplement the financial statements and related Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024”
Seres Therapeutics, Inc. reported first quarter 2024 results: revenue $10.1 million, net income $40.1 million.
“BUSINESS UPDATES Continued market adoption of VOWST ® with approximately 1,411 patient enrollment forms received, approximately 1,083 new patient starts, and net sales of $10.1 million during Q1 2024, and accelerated net sales in March and April SER-155 Phase 1b placebo-controlled Cohort 2 clinical readout expected end of Q3 2024 Further microbiome therapeutic”
Limbach Holdings, Inc. reported the quarter ended March 31, 2024 results: revenue $119.0 million, net income $7.6 million, EPS $0.64 per diluted share. Guidance raised.
“Compared to 2023 First Quarter • ODR revenue increased 26.5%, or $15.5 million, to $74.3 million accounting for 62.4% of consolidated revenue. • Consolidated revenue was $119.0 million, a decrease of 1.7% from $121.0 million. • Total gross profit was $31.1 million, an increase of 18.5% from $26.2 million. • ODR gross profit accounted for $22.2 million, or”
Ashford Inc. reported financial results for the first quarter ended March 31, 2024.
“On May 8, 2024, Ashford Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024.”
1stdibs.com, Inc. updated its first quarter ended March 31, 2024 guidance (reaffirmed).
“On May 8, 2024, 1stdibs.com, Inc. (the “Company”) issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2024.”
RideNow Group, Inc. reported financial results for the three months ended March 31, 2024.
“On May 8, 2024, RumbleOn, Inc. (the “Company”) issued a press release reporting its results for the first quarter ended March 31, 2024.”
Catalent, Inc. reported financial results for third quarter ended March 31, 2024.
“On May 8, 2024, Catalent, Inc. (the " Company ") issued an earnings release setting forth the Company's financial results for its third quarter ended March 31, 2024.”
MAGNITE, INC. reported fiscal quarter ended March 31, 2024 results: revenue $149.3 million, net income $17.8 million, EPS $0.13. Guidance raised.
“the world's largest independent sell-side advertising company, today reported its results of operations for the quarter ended March 31, 2024. Q1 2024 Highlights: • Revenue of $149.3 million, up 15% year-over-year • Contribution ex-TAC (1) of $130.6 million, up 12% year-over-year • Contribution ex-TAC (1) attributable to CTV of $54.9 million, up 18% year-over-year,”
Hamilton Insurance Group, Ltd. reported the first quarter ended March 31, 2024 results: revenue $385.3 million, net income $157.2 million, EPS $1.38.
“• Annualized return on average equity of 29.5%; • Gross premiums written of $721.9 million, an increase of 34.1% compared to the first quarter of 2023; • Net premiums earned of $385.3 million, an increase of 35.7% compared to the first quarter of 2023; • Combined ratio of 91.5%; • Underwriting income of $32.5 million; • Net investment income of $147.8 million,”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.